ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7,1,Headache,Headaches NEC,Headaches,Nerv,N
8,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
9,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
10,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
10,3,Headache,Headaches NEC,Headaches,Nerv,N
11,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
11,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11,5,Headache,Headaches NEC,Headaches,Nerv,N
11,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
12,1,Headache,Headaches NEC,Headaches,Nerv,N
12,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
13,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
13,2,Headache,Headaches NEC,Headaches,Nerv,N
13,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
14,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
15,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
15,2,Headache,Headaches NEC,Headaches,Nerv,N
16,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
16,2,Headache,Headaches NEC,Headaches,Nerv,N
17,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
17,2,Headache,Headaches NEC,Headaches,Nerv,N
18,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
19,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
19,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
19,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
21,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
23,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
24,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
25,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,3,Stasis dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
26,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
26,2,Breast disorder,Breast disorders NEC,Breast disorders,Repro,N
26,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
26,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
28,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
28,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
28,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
29,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
29,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
29,3,Headache,Headaches NEC,Headaches,Nerv,N
29,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
29,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
30,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
31,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
31,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
32,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
32,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
32,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
32,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
33,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
33,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
33,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
33,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
34,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
34,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
34,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
34,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
35,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
35,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
35,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
35,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
35,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
36,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
36,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
36,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
36,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
36,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
37,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
37,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
37,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
37,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
37,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
38,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
38,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
38,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
38,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
39,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
39,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
39,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
39,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
40,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
40,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
40,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
40,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
40,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
41,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
41,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
41,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
41,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
42,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
42,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
43,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
44,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
44,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
45,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
45,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
45,3,Headache,Headaches NEC,Headaches,Nerv,N
45,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
46,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
46,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
47,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
48,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
49,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
49,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
50,2,Haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
51,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
52,1,Anti-erythropoietin antibody positive,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
52,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
53,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
54,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
55,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
56,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
57,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
57,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
57,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
57,4,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
58,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
59,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
60,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
61,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
62,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
63,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
64,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
65,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
66,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
67,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
68,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
68,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
69,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
70,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
71,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
72,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
73,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
74,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
75,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
76,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
77,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
77,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
78,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
79,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
79,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
79,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
80,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
81,1,Leg amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
82,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
83,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
84,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
85,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
86,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
87,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
88,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
89,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
90,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
91,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
92,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
92,2,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
92,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
92,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,5,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
93,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
93,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
93,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
94,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
95,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
96,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
97,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
98,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
99,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
100,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
101,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
102,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
103,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
104,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
105,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
105,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
105,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
105,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
106,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
107,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
108,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
109,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
110,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
111,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
112,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
113,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
114,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
115,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
115,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
116,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
116,2,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
116,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
117,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
117,2,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
118,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
118,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
118,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
119,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
120,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
121,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
122,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
123,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
124,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
124,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
124,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
125,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
126,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
127,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
128,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
129,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
130,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
131,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
132,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
132,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
132,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
132,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
133,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
133,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
134,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
135,1,Arteriovenous fistula,Vascular malformations and acquired anomalies,Vascular disorders NEC,Vasc,N
136,1,Device issue,Device issues NEC,Device issues,Prod,N
137,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
137,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
138,1,Diabetic complication,Diabetic complications NEC,Diabetic complications,Metab,N
139,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
140,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
141,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
142,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
143,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
144,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
144,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
145,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
146,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
147,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
147,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
147,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
148,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
149,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
150,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
151,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
151,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
152,1,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
153,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
154,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
155,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
156,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
157,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
157,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
158,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
159,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
160,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
160,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
160,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
160,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
160,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
160,6,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
160,7,Renal artery stenosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
161,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
161,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
162,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
163,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
164,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
165,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
166,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
166,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
167,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
168,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
169,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
170,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
170,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
171,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
172,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
173,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
173,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
173,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
173,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
173,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
174,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
174,2,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
175,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
176,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
177,1,Skull fracture,"Skull fractures, facial bone fractures and dislocations",Bone and joint injuries,Inj&P,N
178,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
179,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
180,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
181,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
182,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
183,1,Cervical vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
183,2,Disability,Disability issues,Lifestyle issues,SocCi,N
183,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
184,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
185,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
185,2,Hand fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
186,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
187,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
188,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
189,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
190,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
191,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
192,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
193,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
194,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
195,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
196,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
197,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
198,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
199,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
200,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
201,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
202,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
203,1,Urinary tract disorder,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
204,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
205,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
206,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
207,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
208,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
209,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
210,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
211,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
212,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
213,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
214,1,Arterial disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
214,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
214,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
214,4,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
214,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
215,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
216,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
217,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
218,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
219,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
220,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
221,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
222,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
223,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
224,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
225,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
226,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
227,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
228,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
229,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
230,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
231,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
232,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
232,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
232,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
232,4,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
232,5,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
232,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
232,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
233,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
233,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
234,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
235,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
236,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
236,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
237,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
237,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
238,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
239,1,Antiphospholipid syndrome,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
239,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
240,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
241,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
241,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
241,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
241,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
242,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
243,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
243,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
243,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
244,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
245,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
245,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
246,1,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
246,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
247,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
248,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
249,1,Haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
250,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
251,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
252,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
253,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
253,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
253,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
253,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
254,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
255,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
256,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
257,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
257,2,Headache,Headaches NEC,Headaches,Nerv,N
258,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
259,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
260,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
261,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
262,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
262,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
263,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
264,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
265,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
266,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
267,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
268,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
269,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
270,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
271,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
272,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
273,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
274,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
275,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
276,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
277,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
278,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
279,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
280,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
281,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
281,2,Full blood count increased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
282,1,Haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
283,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
284,1,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
285,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
286,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
287,1,Hypertensive crisis,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
288,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
289,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
290,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
291,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
